Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gayatri Devi, MD, The New York Memory Services
ClinicalTrials.gov Identifier:
NCT00814697
First received: December 24, 2008
Last updated: January 8, 2014
Last verified: January 2014
Results First Received: May 2, 2013  
Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study;   Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Conditions: Alzheimer's Disease
Aphasia
Dementia
Intervention: Device: Repetitive Transcranial Magnetic Coil Stimulation (rTMS)

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
All patients were recruited from a tertiary memory disorders practice. Patients were diagnosed as having probable or possible Alzheimer's Disease (AD), using the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
Exclusion criteria included newly diagnosed AD, pacemaker placement, a history of implanted metal object, seizures or epilepsy, a recent history of migraines, uncontrolled depression and those on medications lowering the seizure threshold.

Reporting Groups
  Description
rTMS

rTMS treatment in Alzheimer's disease

Repetitive Transcranial Magnetic Coil Stimulation (rTMS) : Using rTMS to treat language deficits in Alzheimer's patients


Participant Flow:   Overall Study
    rTMS  
STARTED     12  
COMPLETED     12  
NOT COMPLETED     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
rTMS

rTMS treatment in Alzheimer's disease

Repetitive Transcranial Magnetic Coil Stimulation (rTMS) : Using rTMS to treat language deficits in Alzheimer's patients


Baseline Measures
    rTMS  
Number of Participants  
[units: participants]
  12  
Age  
[units: participants]
 
<=18 years     0  
Between 18 and 65 years     3  
>=65 years     9  
Age  
[units: years]
Mean ± Standard Deviation
  73.1  ± 7.9  
Gender  
[units: participants]
 
Female     5  
Male     7  
Region of Enrollment  
[units: participants]
 
United States     12  



  Outcome Measures

1.  Primary:   Cognitive Assessment Task Scores Before, During and After rTMS.   [ Time Frame: 6 weeks ]


  Serious Adverse Events


  Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.  


Results Point of Contact:  
Name/Title: Dr. Gayatri Devi
Organization: The NY Memory and Healthy Aging Services
phone: 212-517-6881
e-mail: gd@nymemory.org


Publications:


Responsible Party: Gayatri Devi, MD, The New York Memory Services
ClinicalTrials.gov Identifier: NCT00814697     History of Changes
Other Study ID Numbers: 91913-5
Study First Received: December 24, 2008
Results First Received: May 2, 2013
Last Updated: January 8, 2014
Health Authority: United States: Institutional Review Board